Department of Medicine, University of Minnesota, Minneapolis, MN; Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN; Center for Chronic Disease Outcomes Research, VA Health Care System, Minneapolis, MN.
California Pacific Medical Center Research Institute, San Francisco, CA.
Am J Kidney Dis. 2014 Jan;63(1):31-9. doi: 10.1053/j.ajkd.2013.05.022. Epub 2013 Jul 24.
Higher serum cystatin C level is associated with an increased risk of hip fracture in postmenopausal white women, but there is a paucity of data for men. Whether estimated glomerular filtration rate (eGFR) based on cystatin C (eGFRcys) is superior in predicting hip fracture risk to eGFR based on creatinine (eGFRcr) or the combination (eGFR(cr-cys)) also is uncertain.
Nested case-cohort.
SETTING & PARTICIPANTS: Participants enrolled in the Osteoporotic Fractures in Men (MrOS) Study (5,994 men aged ≥ 65 years from 6 US centers) including a random subcohort of 1,602 men and 168 men with incident hip fractures (51 of whom were in the subcohort).
eGFR(cys), eGFR(cr), and eGFR(cr-cys) computed using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and expressed in categories of <60, 60-74, and ≥ 75 mL/min/1.73 m(2) (referent group).
Incident hip fracture ascertained by participant contacts every 4 months and confirmed with radiographic reports.
Median eGFR(cys) was 72.9 (IQR, 60.5-85.7) mL/min/1.73 m(2). In unadjusted models, all measures of eGFR were associated with increased hip fracture risk. However, after adjustment for age, race, site, and body mass index, the association of lower eGFR(cys) (but not lower eGFR(cr) or lower eGFR(cr-cys)) with higher hip fracture risk remained: for <60 versus ≥ 75 mL/min/1.73 m(2), HRs were 1.96 [95% CI, 1.25-3.09], 0.84 [95% CI, 0.52-1.37], and 1.08 [95% CI, 0.66-1.77] for eGFR(cys), eGFR(cr), and eGFR(cr-cys), respectively. Similarly, after adjustment for age, race, site, and body mass index, eGFR < 60 mL/min/1.73 m(2) defined by eGFR(cys), but not eGFR(cr) or eGFR(cr-cys), was associated with higher hip fracture risk. The association between eGFR(cys) and hip fracture was not explained by levels of calciotropic hormones or inflammatory markers, but the relationship was attenuated and no longer reached significance (for <60 vs ≥ 75 mL/min/1.73 m(2): HR, 1.43; 95% CI, 0.88-2.34) after consideration of additional clinical risk factors and bone mineral density.
Findings not generalizable to other populations; residual confounding may exist.
Older community-dwelling men with lower eGFR(cys) have an increased risk of hip fracture that is explained in large part by greater burden of risk factors among men with lower eGFR(cys). In contrast, lower eGFR(cr) or lower eGFR(cr-cys) was not associated with a higher age-adjusted hip fracture risk.
较高的血清胱抑素 C 水平与绝经后白人女性髋部骨折的风险增加相关,但男性的数据较少。基于胱抑素 C(eGFRcys)的估计肾小球滤过率(eGFR)是否优于基于肌酐(eGFRcr)或两者的组合(eGFR(cr-cys))预测髋部骨折风险尚不确定。
巢式病例对照研究。
参加男性骨质疏松症(MrOS)研究的参与者(来自 6 个美国中心的 5994 名年龄≥65 岁的男性),包括 1602 名男性和 168 名髋部骨折的男性(其中 51 名在子队列中)。
使用 CKD-EPI(慢性肾脏病流行病学合作)方程计算的 eGFR(cys)、eGFR(cr)和 eGFR(cr-cys),并以<60、60-74 和≥75 mL/min/1.73 m2(参考组)的类别表示。
通过每 4 个月与参与者联系并通过放射报告确认的髋部骨折的发生情况。
中位数 eGFR(cys)为 72.9(IQR,60.5-85.7)mL/min/1.73 m2。在未调整的模型中,所有 eGFR 测量值都与髋部骨折风险增加相关。然而,在调整年龄、种族、部位和体重指数后,较低的 eGFR(cys)(但不是较低的 eGFR(cr)或较低的 eGFR(cr-cys))与较高的髋部骨折风险仍相关:<60 与≥75 mL/min/1.73 m2,HRs 分别为 1.96 [95% CI,1.25-3.09]、0.84 [95% CI,0.52-1.37]和 1.08 [95% CI,0.66-1.77]对于 eGFR(cys)、eGFR(cr)和 eGFR(cr-cys)。同样,在调整年龄、种族、部位和体重指数后,eGFR <60 mL/min/1.73 m2 定义为 eGFR(cys),而不是 eGFR(cr)或 eGFR(cr-cys),与较高的髋部骨折风险相关。eGFR(cys)与髋部骨折之间的关联不能用钙调节激素或炎症标志物的水平来解释,但在考虑了其他临床危险因素和骨密度后,这种关系减弱且不再具有统计学意义(<60 与≥75 mL/min/1.73 m2:HR,1.43;95% CI,0.88-2.34)。
研究结果不能推广到其他人群;可能存在残余混杂。
年龄较大的社区居住男性,如果 eGFR(cys)较低,髋部骨折的风险会增加,这在很大程度上可以解释为 eGFR(cys)较低的男性的危险因素负担更大。相比之下,较低的 eGFR(cr)或较低的 eGFR(cr-cys)与调整年龄后的髋部骨折风险增加无关。